Sign In
Buy BIO
$304.83
-1.30 (-0.425%)
At Close: Jun 03, 2026
$3.5 Bn Blood Screening Market by Technology, Product, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com
12:00am, Monday, 20'th Jul 2020
The
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by CENTRAL TRUST Co
07:46am, Friday, 17'th Jul 2020
CENTRAL TRUST Co decreased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 57.4% during the 2nd quarter, HoldingsChannel reports. The firm owned 876 shares of the medical research company’s st
In-Vitro Diagnostics Market: Analysis, Trends and Forecasts to 2028 - ResearchAndMarkets.com
12:00am, Friday, 17'th Jul 2020
The
Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020
12:01am, Thursday, 16'th Jul 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2020 on Thursday, July
Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020
12:00am, Thursday, 16'th Jul 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial resu
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
12:00am, Wednesday, 15'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Altimmune Inc (NASDAQ: ALT...
Did Hedge Funds Make The Right Call On Bio-Rad Laboratories, Inc. (BIO) ?
12:12am, Tuesday, 14'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Merck : Changes in Merck KGaA, Darmstadt, Germany, Executive Board | MarketScreener
01:06pm, Monday, 13'th Jul 2020The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
12:00am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon
07:57pm, Thursday, 09'th Jul 2020
If approved, company’s Roctavian would become first gene therapy for inherited disease Continue reading...
Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes
01:32pm, Thursday, 09'th Jul 2020
Bio-Rad (BIO) rides on the FDA's emergency use authorization EUA for the Droplet Digital PCR COVID-19 test kit.
